First Trust NYSE Arca Biotechnology Index Fund Rating $164.86 -1.86 (-1.12%) As of 03/28/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.65Holdings in FBT have an aggregate rating of Moderate Buy based on 538 analyst ratings issued in the past year covering 30 companies (99.9% of the portfolio).FBT Aggregate Price Target$164.86High Prediction$164.86Average Prediction$164.86Low Prediction$164.86Holdings in FBT have an aggregate price target of $164.86 and a range of $164.86 to $164.86 covering 30 companies (99.9% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 FBT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.00%ONCBeigene$267.39+1.8%1.1482 of 5 stars3.00$310.00 15.9%34.62%ITCIIntra-Cellular Therapies$131.81+0.0%3.5737 of 5 stars2.47$106.08 -19.5%15Analyst ForecastNews CoveragePositive News4.18%VRTXVertex Pharmaceuticals$492.69-2.0%3.8352 of 5 stars2.65$506.70 2.8%26News CoveragePositive News4.17%GILDGilead Sciences$111.79+0.6%4.5801 of 5 stars2.72$105.12 -6.0%29Positive News4.08%ALKSAlkermes$33.21-1.0%4.6011 of 5 stars2.69$39.38 18.6%13Positive News4.03%AMGNAmgen$306.95+0.4%4.4282 of 5 stars2.48$314.04 2.3%23Analyst UpgradePositive News3.98%HALOHalozyme Therapeutics$63.84-1.0%4.2631 of 5 stars2.60$62.78 -1.7%10News CoveragePositive News3.87%CORTCorcept Therapeutics$54.63-3.6%4.3354 of 5 stars3.00$99.75 82.6%53.55%ALNYAlnylam Pharmaceuticals$268.46-0.9%4.2391 of 5 stars2.76$312.30 16.3%25News Coverage3.54%BMRNBioMarin Pharmaceutical$71.44-1.9%4.9235 of 5 stars2.71$94.00 31.6%24Options VolumeNews CoveragePositive News3.43%EXELExelixis$36.70-0.4%4.5277 of 5 stars2.50$37.59 2.4%20Upcoming EarningsAnalyst RevisionPositive News3.40%MTDMettler-Toledo International$1,176.04-1.4%3.6772 of 5 stars2.11$1,380.50 17.4%9Positive News3.32%ACADACADIA Pharmaceuticals$17.07-0.7%4.1264 of 5 stars2.50$23.93 40.2%163.32%WATWaters$361.61-2.4%3.9534 of 5 stars2.59$397.40 9.9%173.29%RGENRepligen$133.41-2.7%4.7395 of 5 stars2.57$178.64 33.9%14News Coverage3.25%REGNRegeneron Pharmaceuticals$637.36+0.2%4.8124 of 5 stars2.76$973.13 52.7%25Short Interest ↑Positive News3.22%BIIBBiogen$138.37-1.4%4.8973 of 5 stars2.43$213.33 54.2%30Positive News3.13%GMABGenmab A/S$19.90-1.2%3.9285 of 5 stars2.77$41.33 107.7%13Short Interest ↑News CoverageGap Down3.12%ARGXargenx$589.15-0.7%3.3711 of 5 stars2.91$687.00 16.6%23Positive News2.95%UTHRUnited Therapeutics$306.97-0.3%4.9334 of 5 stars2.67$388.25 26.5%12Insider TradeShort Interest ↓News CoveragePositive News2.93%INCYIncyte$60.60-0.1%4.6928 of 5 stars2.21$74.88 23.6%19Positive News2.85%NTRANatera$143.94-2.9%3.1097 of 5 stars3.00$178.12 23.7%16Short Interest ↑Positive News2.74%MRNAModerna$31.12-3.1%4.0996 of 5 stars2.04$59.00 89.6%242.74%BNTXBioNTech$94.95-0.5%2.347 of 5 stars2.89$143.73 51.4%182.71%SRPTSarepta Therapeutics$70.41-1.9%4.8322 of 5 stars2.83$167.41 137.8%232.67%EXASExact Sciences$43.66-3.0%4.4953 of 5 stars2.90$70.26 60.9%21Analyst ForecastPositive News2.64%NBIXNeurocrine Biosciences$113.16-0.7%4.9192 of 5 stars2.83$165.38 46.1%23Positive News2.58%BRKRBruker$42.08-3.2%4.6713 of 5 stars2.55$70.50 67.5%11Short Interest ↑News CoveragePositive News2.51%VCYTVeracyte$30.12-3.2%4.531 of 5 stars2.70$43.40 44.1%10Analyst ForecastNews CoveragePositive News2.09%ILMNIllumina$80.00-2.8%4.7706 of 5 stars2.48$140.90 76.1%21Positive News This page (NYSEARCA:FBT) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FBT Stock Free FBT Stock Alerts